跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NPS-4
首页
药物
NPS-4
NPS-4
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Porcine circovirus type 4-based protein nanoparticle, porcine delta coronavirus vaccine and application
申请人: UNIV HUNAN AGRICULTURAL
优先权: 2025
CN
HGF/CAT double-gene nano-drug as well as preparation method and application thereof
申请人: UNIV FUJIAN MEDICAL
优先权: 2024
CN
Temperature response controlled release system based on base-like pairing rule and application of temperature response controlled release system in preparation of rheumatoid arthritis treatment medicine
申请人: UNIV NANJING CHINESE MEDICINE
优先权: 2025
CN
pH-sensitive hydroxyapatite (HA)/zein nano-drug carrier and application thereof
申请人: UNIV ANHUI CHINESE MEDICINE
优先权: 2019
CN
Bionic nano delivery system ANG-2-CMLNPs
申请人: UNIV CAPITAL MEDICAL SCIENCES
优先权: 2026
CN
Elagic acid-divalent manganese metal organic framework and preparation method thereof, and anti-tumor targeting nano material
申请人: TIANFU JINCHENG LABORATORY FRONTIER MEDICAL CENTER
优先权: 2025
CN
Preparation method and application of polymer polyphenol drug-loaded nano system
申请人: UNIV LANZHOU
优先权: 2023
CN
Sound-sensitive agent molecule and application thereof in anti-tumor/bacterial treatment
申请人: UNIV HEBEI
优先权: 2025
CN
药物
反馈